Search research articles
Contact Us
Filters
Showing results (31-40 of 96) with videos related to
Page
of 10
Sort By:
Cancer Treatment Reviews
|
March 6, 2022
Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategies
María San Román-Gil, Javier Pozas, Diana Rosero-Rodríguez, et al.
Drugs in R&D
|
May 24, 2026
A Combination of the Tryptophan Hydroxylase Inhibitor Telotristat with the mTOR Inhibitor Everolimus as an Effective Strategy Against Neuroendocrine Tumors
Javier Molina-Cerrillo, Arantzazu Sierra-Ramirez, José L López-Aceituno, et al.
Therapeutic Advances in Urology
|
September 23, 2021
The effect of medical and urologic disorders on the survival of patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide
Juan José Serrano Domingo, Teresa Alonso Gordoa, Javier Lorca Álvaro, et al.
Annales D'Endocrinologie
|
November 5, 2022
Surgical and non-surgical management of thoracic and cervical paraganglioma
Marta Araujo-Castro, Sandra Redondo López, Eider Pascual-Corrales, et al.
International Journal of Molecular Sciences
|
November 17, 2020
Tyrosine Kinase Receptors in Oncology
Jorge Esteban-Villarrubia, Juan José Soto-Castillo, Javier Pozas, et al.
International Journal of Molecular Sciences
|
January 16, 2021
Novel Tyrosine Kinase Targets in Urothelial Carcinoma
Javier Torres-Jiménez, Víctor Albarrán-Fernández, Javier Pozas, et al.
Frontiers in Immunology
|
May 1, 2026
An agent-based learning model integrating sex differences in renal cell carcinoma
Emanuela Merelli, Tarek Taha, Marco Caputo, et al.
Endocrine Pathology
|
July 3, 2024
Transcriptomic Differences in Medullary Thyroid Carcinoma According to Grade
Ignacio Ruz-Caracuel, Tamara Caniego-Casas, Teresa Alonso-Gordoa, et al.
Cancer Immunology, Immunotherapy : CII
|
January 12, 2023
Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis
Matteo Santoni, Alessandro Rizzo, Jakub Kucharz, et al.
Cancers
|
September 9, 2022
Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 Study
Alessandro Rizzo, Veronica Mollica, Andrea Marchetti, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 96) with videos related to
Sort By:
Page
of 10
Cancer Treatment Reviews
|
March 6, 2022
Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategies
María San Román-Gil, Javier Pozas, Diana Rosero-Rodríguez, et al.
Drugs in R&D
|
May 24, 2026
A Combination of the Tryptophan Hydroxylase Inhibitor Telotristat with the mTOR Inhibitor Everolimus as an Effective Strategy Against Neuroendocrine Tumors
Javier Molina-Cerrillo, Arantzazu Sierra-Ramirez, José L López-Aceituno, et al.
Therapeutic Advances in Urology
|
September 23, 2021
The effect of medical and urologic disorders on the survival of patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide
Juan José Serrano Domingo, Teresa Alonso Gordoa, Javier Lorca Álvaro, et al.
Annales D'Endocrinologie
|
November 5, 2022
Surgical and non-surgical management of thoracic and cervical paraganglioma
Marta Araujo-Castro, Sandra Redondo López, Eider Pascual-Corrales, et al.
International Journal of Molecular Sciences
|
November 17, 2020
Tyrosine Kinase Receptors in Oncology
Jorge Esteban-Villarrubia, Juan José Soto-Castillo, Javier Pozas, et al.
International Journal of Molecular Sciences
|
January 16, 2021
Novel Tyrosine Kinase Targets in Urothelial Carcinoma
Javier Torres-Jiménez, Víctor Albarrán-Fernández, Javier Pozas, et al.
Frontiers in Immunology
|
May 1, 2026
An agent-based learning model integrating sex differences in renal cell carcinoma
Emanuela Merelli, Tarek Taha, Marco Caputo, et al.
Endocrine Pathology
|
July 3, 2024
Transcriptomic Differences in Medullary Thyroid Carcinoma According to Grade
Ignacio Ruz-Caracuel, Tamara Caniego-Casas, Teresa Alonso-Gordoa, et al.
Cancer Immunology, Immunotherapy : CII
|
January 12, 2023
Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis
Matteo Santoni, Alessandro Rizzo, Jakub Kucharz, et al.
Cancers
|
September 9, 2022
Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 Study
Alessandro Rizzo, Veronica Mollica, Andrea Marchetti, et al.
Page
of 10